
GE Healthcare Technologies Inc
NASDAQ:GEHC

Intrinsic Value
The intrinsic value of one
GEHC
stock under the Base Case scenario is
93.21
USD.
Compared to the current market price of 60.48 USD,
GE Healthcare Technologies Inc
is
Undervalued by 35%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
GE Healthcare Technologies Inc
Fundamental Analysis

GE HealthCare’s reliance on large-scale capital equipment sales may face headwinds if hospital budgets tighten, leading to slower revenue growth in its flagship imaging solutions segment. Extended sales cycles or delayed purchasing decisions could hurt topline momentum.
Strong demand for advanced diagnostic imaging and precision health solutions, driven by an aging global population and a rising burden of chronic diseases, underpins substantial long-term growth potential for GE HealthCare’s core product lines.

Revenue & Expenses Breakdown
GE Healthcare Technologies Inc
Balance Sheet Decomposition
GE Healthcare Technologies Inc
Current Assets | 9.9B |
Cash & Short-Term Investments | 2.9B |
Receivables | 4.7B |
Other Current Assets | 2.3B |
Non-Current Assets | 23.2B |
Long-Term Investments | 373m |
PP&E | 2.6B |
Intangibles | 14.2B |
Other Non-Current Assets | 6.1B |
Free Cash Flow Analysis
GE Healthcare Technologies Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
GE Healthcare Technologies Inc
Revenue
|
19.7B
USD
|
Cost of Revenue
|
-11.5B
USD
|
Gross Profit
|
8.2B
USD
|
Operating Expenses
|
-5.6B
USD
|
Operating Income
|
2.6B
USD
|
Other Expenses
|
-632m
USD
|
Net Income
|
2B
USD
|
GEHC Profitability Score
Profitability Due Diligence
GE Healthcare Technologies Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Score
GE Healthcare Technologies Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
GEHC Solvency Score
Solvency Due Diligence
GE Healthcare Technologies Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Score
GE Healthcare Technologies Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GEHC Price Targets Summary
GE Healthcare Technologies Inc
According to Wall Street analysts, the average 1-year price target for
GEHC
is 102.57 USD
with a low forecast of 74.74 USD and a high forecast of 120.75 USD.
Dividends
Current shareholder yield for GEHC is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
GEHC
stock under the Base Case scenario is
93.21
USD.
Compared to the current market price of 60.48 USD,
GE Healthcare Technologies Inc
is
Undervalued by 35%.